0001567619-21-011362.txt : 20210528
0001567619-21-011362.hdr.sgml : 20210528
20210528162448
ACCESSION NUMBER: 0001567619-21-011362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210526
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBBINS LARRY
CENTRAL INDEX KEY: 0001228603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39292
FILM NUMBER: 21980577
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
FORMER NAME:
FORMER CONFORMED NAME: ROBBINS LAWRENCE M
DATE OF NAME CHANGE: 20030423
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Butterfly Network, Inc.
CENTRAL INDEX KEY: 0001804176
STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 OLD WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
BUSINESS PHONE: 203-689-5650
MAIL ADDRESS:
STREET 1: 530 OLD WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
FORMER COMPANY:
FORMER CONFORMED NAME: Longview Acquisition Corp.
DATE OF NAME CHANGE: 20200220
4
1
doc1.xml
FORM 4
X0306
4
2021-05-26
0
0001804176
Butterfly Network, Inc.
BFLY
0001228603
ROBBINS LARRY
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
1
0
1
0
Class A Common Stock
2021-05-26
4
P
0
150000
11.0933
A
4924846
I
See footnotes
Class A Common Stock
2021-05-27
4
P
0
39905
11.0963
A
4964751
I
See footnotes
Class A Common Stock
13157
D
Class A Common Stock
10275000
I
See footnotes
These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Healthcare Master Fund, L.P.
This price reflects the weighted average price for open-market purchases of Shares on May 26, 2021 within a $1.00 range. The actual prices for these transactions range from $11.03 to $11.13, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price.
These shares were purchased by Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P. and Glenview Offshore Opportunity Master Fund, Ltd.
This price reflects the weighted average price for open-market purchases of Shares on May 27, 2021 within a $1.00 range. The actual prices for these transactions range from $11.06 to $11.10, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price.
Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the shares held by the Glenview Investment Funds and may be deemed to beneficially own such shares.
Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these Shares. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the shares held by Longview and may be deemed to beneficially own such shares.
Mr. Robbins disclaims beneficial ownership over any Shares owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one Share upon vesting. The RSUs vest in equal annual installments over three years beginning on February 16, 2022, subject to Mr. Robbins' continued service through the applicable vesting date.
Exhibit List: The Power of Attorney filed as Exhibit B to the Schedule 13G filed by Glenview Capital Management LLC on April 22, 2021 is incorporated herein by reference.
/s/ Mark J. Horowitz, attorney-in-fact for Larry Robbins
2021-05-28